These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3312146

  • 1. Current controversies. Histiocytosis-X.
    McLelland J, Pritchard J, Chu AC.
    Hematol Oncol Clin North Am; 1987 Mar; 1(1):147-62. PubMed ID: 3312146
    [Abstract] [Full Text] [Related]

  • 2. The histopathology of Langerhans cell histiocytosis.
    Favara BE, Jaffe R.
    Br J Cancer Suppl; 1994 Sep; 23():S17-23. PubMed ID: 7521200
    [Abstract] [Full Text] [Related]

  • 3. Histiocytosis-X: an overview.
    Osband ME, Pochedly C.
    Hematol Oncol Clin North Am; 1987 Mar; 1(1):1-7. PubMed ID: 3499430
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders.
    Lau SK, Chu PG, Weiss LM.
    Am J Surg Pathol; 2008 Apr; 32(4):615-9. PubMed ID: 18277880
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An hypothesis Langerhans cell histiocytosis: the failure of the immune system to switch from an innate to an adaptive mode.
    Nezelof C, Basset F.
    Pediatr Blood Cancer; 2004 May; 42(5):398-400. PubMed ID: 15049008
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Langerhans cell histiocytosis: a pathologic combination of oncogenesis and immune dysregulation.
    Egeler RM, Annels NE, Hogendoorn PC.
    Pediatr Blood Cancer; 2004 May; 42(5):401-3. PubMed ID: 15049009
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD1 (OKT6)-positive juvenile xanthogranuloma. OKT6 is not specific for Langerhans cell histiocytosis (histiocytosis X).
    Andersen WK, Knowles DM, Silvers DN.
    J Am Acad Dermatol; 1992 May; 26(5 Pt 2):850-4. PubMed ID: 1613148
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical and immunohistochemical evaluation of the vulvar Langerhans cell histiocytosis.
    Bongiorno MR, Pistone G, de Giorgi V, Aricò M.
    Dermatol Ther; 2008 May; 21 Suppl 3():S15-20. PubMed ID: 19076626
    [Abstract] [Full Text] [Related]

  • 15. [Isolated cutaneous Langerhans histiocytosis. Clinical and immunohistologic improvement after local application of nitrogen mustard].
    Thivolet J, Cambazard F, Euvrard S, Hermier M, Kanitakis J.
    Ann Dermatol Venereol; 1984 May; 111(8):765-6. PubMed ID: 6397098
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Capsule dermatopathology: dysplastic and malignant histiocytic infiltrates in the skin.
    Nickoloff BJ, Murphy GF.
    J Dermatol Surg Oncol; 1983 Jul; 9(7):513-6. PubMed ID: 6222089
    [No Abstract] [Full Text] [Related]

  • 19. Langerhans cell histiocytosis research. Past, present, and future.
    Nezelof C, Basset F.
    Hematol Oncol Clin North Am; 1998 Apr; 12(2):385-406. PubMed ID: 9561908
    [Abstract] [Full Text] [Related]

  • 20. Biochemistry and biology of the Langerhans cell.
    Ishii E, Watanabe S.
    Hematol Oncol Clin North Am; 1987 Mar; 1(1):99-118. PubMed ID: 3312152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.